MRI Interventions (MRIC) Stock Price, News & Analysis

Company Overview

MRI Interventions, Inc. was a medical technology company focused on developing and commercializing minimally invasive systems for procedures involving the brain. Its technology was designed to help neurosurgeons plan, guide and monitor interventions using magnetic resonance imaging (MRI), with the goal of improving precision and reducing the invasiveness of treatment.

The company’s principal product was the ClearPoint system, an MRI-compatible platform used to guide instruments during neurosurgical procedures. The platform was developed for applications including the placement of deep-brain stimulation leads, targeted drug delivery and other image-guided interventions. MRI Interventions also developed related accessories and devices intended to support minimally invasive neurological procedures.

MRI Interventions operated primarily in the United States through relationships with hospitals, physicians and research institutions. In 2020, the company changed its name to ClearPoint Neuro, Inc., reflecting its broader focus on image-guided and navigation technologies for brain procedures. The company is therefore generally identified in more recent corporate materials as ClearPoint Neuro rather than MRI Interventions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 51,600 shs
• Average Volume: 63,036 shs
• Market Capitalization: $78.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 5/15/2018
• Today: 10/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:MRIC
• CIK: 1285550
• Web: www.mriinterventions.com
• Phone: (949) 900-6833
• Fax: N/A
• Employees: 38
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 15,206,000
• Free Float: N/A
• Market Cap: $78.16 million
• Optionable: Not Optionable
• Beta: N/A